Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

被引：0

作者：

Chen, Jiaoting ^{[1
]}

Su, Ning ^{[1
]}

Huang, Yan ^{[2
]}

Zhang, Min ^{[3
]}

Yao, Jiayin ^{[3
]}

Li, Guolin ^{[4
]}

Ma, Tenghui ^{[5
]}

Zhi, Min ^{[3
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hematol, Guangzhou, Guangdong, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China

[4] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China

[5] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China

来源：

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2024年 / 116卷 / 03期

关键词：

Indolent T-cell lymphoproliferative disorder; Ulcerative colitis; Tumor necrosis factor-alpha inhibitor; LYMPHOPROLIFERATIVE DISORDER;

D O I：

10.17235/reed.2023.9623/2023

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Indolent T-cell lymphoma is a rare disease. Here we presented a 53-year-old male patient initially diagnosed as ulcerative colitis in 2000 that finally developed into extensive indolent T-cell lymphoma in 2022. We also described the differences between indolent T-cell lymphoma and inflammatory bowel disease, and the possible disease progression into lymphoma after biological therapy.

引用

页码：165 / 166

页数：2

共 50 条

[21] Primary cutaneous peripheral T-cell lymphoma, unspecified, with an indolent clinical course: a distinct peripheral T-cell lymphoma?
Ryan, A.
Hayes, B.
Robson, A.
Sheahan, K.
Collins, P.
BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 57 - 57
[22] Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma?
Ryan, A. J. A.
Robson, A.
Hayes, B. D.
Sheahan, K.
Collins, P.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 892 - 896
[23] MercaptopurineHepatosplenic T-cell lymphoma and rebound ulcerative colitis following discontinuation of mercaptopurine : case report
Reactions Weekly, 2024, 2017 (1) : 276 - 276
[24] Hepatosplenic T-Cell Lymphoma Secondary to 6-Mercaptopurine in Ulcerative Colitis: A Case Report
Maheshwari, Priya Kumari
Fahim, Peter
Bets, Iryna
Yoo, Jun
Harrison, Anil
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2554 - S2554
[25] Intestinal T-cell lymphoma presenting as colonic perforation in the setting of ulcerative colitis: a case report
Mourad, Ali Phillip
De Robles, Marie Shella
Winn, Robert Duncan
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 176 - 180
[26] Intestinal T-cell lymphoma presenting as colonic perforation in the setting of ulcerative colitis: a case report
Ali Phillip Mourad
Marie Shella De Robles
Robert Duncan Winn
Clinical Journal of Gastroenterology, 2021, 14 : 176 - 180
[27] Blastic morphology of a hepatosplenic T cell lymphoma in a patient treated by immunosuppressive drugs for ulcerative colitis
Lambert, Barbara
Jurdan, Maryvonne
Topciu, Lucian
Robin, Valerie
Kornreich, Anne
HEMATOLOGIE, 2020, 26 (01): : 50 - 56
[28] T-cell malignant lymphoma with conjunctival involvement
Hu, FR
Lin, JC
Chiang, IP
Yeh, KH
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 125 (05) : 717 - 719
[29] Angioimmunoblastic T-cell lymphoma with cutaneous involvement
Mahendran, R
Grant, JW
Hoggarth, CE
Burrows, NP
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (06) : 589 - 590
[30] Peripheral T-cell Lymphoma With Endobronchial Involvement
Ferrer, Gustavo
Gutierrez, Guillermo
Schwartz, Arnold M.
Delaney, Morgan D.
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2010, 17 (02) : 169 - 170

← 1 2 3 4 5 →